
Aesthetic Medicine Market Report 2026
Global Outlook – By Product (Facial Aesthetic Products, Body Contouring Devices, Cosmetic Implants, Hair Removal Devices, Skin Aesthetic Devices, Other Products), By Procedure Type (Invasive Procedures, Non-Invasive Procedures), By End-User (Hospitals And Clinics, Medical Spas And Beauty Centres, Home Care) – Market Size, Trends, Strategies, and Forecast to 2035
Aesthetic Medicine Market Overview
• Aesthetic Medicine market size has reached to $73.7 billion in 2025 • Expected to grow to $110.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Urbanization And Rising Disposable Income Fuel Surge In Aesthetic Medicine Market • Market Trend: Technological Advancements in the Aesthetic Medicine Market to Enhance Non‑Invasive Rejuvenation and Patient Comfort • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Aesthetic Medicine Market?
Aesthetic medicine refers to a growing field of medicine that is separate from plastic surgery and offers minimally invasive medical procedures to improve patients' pleasure with their physical appearance. These elective operations are carried out on healthy adult patients. The medical aesthetic treatments carried out through these aesthetic medicine products include non-invasive lipolysis, hair restoration and removal, cellulite reduction, wrinkle reduction, skin renewal & resurfacing, and others. The main products of aesthetic medicine include facial aesthetic products, body contouring devices, cosmetic implants, hair removal devices, skin aesthetic devices, and others. The facial aesthetic refers to the products used in facial aesthetic treatments and procedures. Facial aesthetics consists of a range of non-surgical treatments performed on the face, which include Botox, fillers, and anti-wrinkle injections. The types of procedures in aesthetic medicine include invasive procedures and non-invasive procedures. They are used in clinics, hospitals, and medical spas, beauty centers, and home care units.
What Is The Aesthetic Medicine Market Size and Share 2026?
The aesthetic medicine market size has grown strongly in recent years. It will grow from $73.7 billion in 2025 to $80.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growing awareness of cosmetic procedures, technological limitations in non-invasive devices, high cost of surgical procedures, limited accessibility to professional aesthetic services, lack of standardization in aesthetic medicine practices.What Is The Aesthetic Medicine Market Growth Forecast?
The aesthetic medicine market size is expected to see strong growth in the next few years. It will grow to $110.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to innovation in non-invasive technologies, increasing adoption of AI-driven treatment planning, rise in disposable income and cosmetic spending, expansion of medical aesthetic infrastructure in emerging regions, personalized and precision aesthetic treatments. Major trends in the forecast period include rise of minimally invasive procedures, growth of non-surgical cosmetic treatments, increasing demand for personalized aesthetic solutions, expansion of medical spas and beauty clinics, technological advancements in skin and hair devices.Global Aesthetic Medicine Market Segmentation
1) By Product: Facial Aesthetic Products, Body Contouring Devices, Cosmetic Implants, Hair Removal Devices, Skin Aesthetic Devices, Other Products 2) By Procedure Type: Invasive Procedures, Non-Invasive Procedures 3) By End-User: Hospitals And Clinics, Medical Spas And Beauty Centres, Home Care Subsegments: 1) By Facial Aesthetic Products: Dermal Fillers, Botox And Neurotoxins, Chemical Peels 2) By Body Contouring Devices: Cryolipolysis Devices, Radiofrequency Devices, Ultrasound Devices 3) By Cosmetic Implants: Breast Implants, Facial Implants, Body Implants 4) By Hair Removal Devices: Laser Hair Removal Devices, Intense Pulsed Light (IPL) Devices 5) By Skin Aesthetic Devices: Microneedling Devices, Laser Skin Resurfacing Devices, LED Therapy Devices 6) By Other Products: Skin Tightening Devices, Cellulite Reduction Devices, Anti-Aging ProductsWhat Is The Driver Of The Aesthetic Medicine Market?
Rapid urbanization and a rise in disposable income are expected to propel the growth of the aesthetic medicine market in the forecast period. The rise in disposable income increases the personal care spending of consumers and the affordability of high-end products has led to the demand for aesthetic medicine. In addition to this, the urban population is more conscious of their looks contributing to the demand for aesthetic medicine. For instance, according to the United Nations, by 2050, it is estimated that around 68% of the total world population will live in urban areas, up from 55% of the world's population living in urban areas currently. Also, according to the data published by Fitch Solutions, a US-based research company, personal care, and effects spending will reach IDR3,802bn ($45.3 billion) in 2026, an average increase of 11.8% annually, from IDR2,527.5bn ($33.3 billion) in 2022. Therefore, rapid urbanization and a rise in disposable income will drive the growth of the market.Key Players In The Global Aesthetic Medicine Market
Major companies operating in the aesthetic medicine market are AbbVie, Johnson & Johnson, Galderma, Bausch Health, Shanghai Fosun Pharmaceutical Co, Cynosure, El.En. S.p.A, Cutera, Merz Pharma, Syneron Candela, Vive Cosmetics, VLCC Personal Care, Kazima Cosmetics, SoftFil, Sinclair Pharma, BIOXIS Pharmaceuticals, Premium Aesthetics LLC, Martinex, Medical Esthetic, Ipsen Pharma, Ruby Surgery & Aesthetics, Medicina Estética Regenerativa, Xcite Technologies, ReNue Aesthetic Medicine, VYDENCE Medical, Julphar, Aspen Pharmacare, Altis Biologics, Cipla Medpro, Sanofi GenzymeGlobal Aesthetic Medicine Market Trends and Insights
Major companies operating in the aesthetic medicine market are focusing on technological advancements, such as next‑generation RF microneedling systems, to meet the rising demand for minimally invasive skin rejuvenation, collagen stimulation, and skin tightening with shorter downtime. RF microneedling technology combines traditional microneedling with radiofrequency energy: insulated or non-insulated needles create micro‑channels in the skin while delivering RF energy into the dermis, promoting collagen and elastin production more effectively than manual microneedling, and doing so with greater precision and less discomfort compared to more aggressive laser resurfacing. For instance, in July 2024, Crescita Therapeutics, a Canada‑based medical device company, announced the device MicronJet 600, an intradermal delivery system using MEMS (micro‑electromechanical systems) technology to enable virtually pain-free injections and precise substance delivery into the skin. The MicronJet 600 utilizes a microarray of microneedles to accurately target the dermal layer with fine control, minimizes trauma to superficial tissues, and enhances the delivery of active ingredients or energy-based modalities with reduced patient discomfort and better treatment outcomes. This device is especially suited for aesthetic applications like skin remodeling, anti-aging, and scar therapy, offering a less invasive yet highly effective alternative to traditional injections or resurfacing procedures.What Are Latest Mergers And Acquisitions In The Aesthetic Medicine Market?
In September2024, ARCHIMED, a France-based private equity firm acquired Jeisys Medical for an undisclosed amount. With this acquisition, ARCHIMED's aims to support Jeisys Medical's growth in the non-invasive aesthetic medicine market and delisting the company from the Korea Exchange. Jeisys Medical is a South Korea-based manufacturer of aesthetics medcines.Regional Insights
North America was the largest region in the aesthetic medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Aesthetic Medicine Market?
The aesthetic medicine market consists of sales of chemical peels, cosmetic dermatology treatments, dermal fillers, and hair transplants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Aesthetic Medicine Market Report 2026?
The aesthetic medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the aesthetic medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Aesthetic Medicine Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $80.09 billion |
| Revenue Forecast In 2035 | $110.76 billion |
| Growth Rate | CAGR of 8.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Procedure Type, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | AbbVie, Johnson & Johnson, Galderma, Bausch Health, Shanghai Fosun Pharmaceutical Co, Cynosure, El.En. S.p.A, Cutera, Merz Pharma, Syneron Candela, Vive Cosmetics, VLCC Personal Care, Kazima Cosmetics, SoftFil, Sinclair Pharma, BIOXIS Pharmaceuticals, Premium Aesthetics LLC, Martinex, Medical Esthetic, Ipsen Pharma, Ruby Surgery & Aesthetics, Medicina Estética Regenerativa, Xcite Technologies, ReNue Aesthetic Medicine, VYDENCE Medical, Julphar, Aspen Pharmacare, Altis Biologics, Cipla Medpro, Sanofi Genzyme |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
